Pacific Edge Limited (PEB.AX)
AUD 0.08
(0.0%)
AUD 0.08
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 14.31 Million NZD | 39.39% |
| 2023 | 10.26 Million NZD | 107.54% |
| 2022 | 4.94 Million NZD | 249.28% |
| 2021 | -3.31 Million NZD | -308.63% |
| 2020 | -811 Thousand NZD | -4.38% |
| 2019 | -777 Thousand NZD | 86.13% |
| 2018 | -5.6 Million NZD | -186.89% |
| 2017 | -1.95 Million NZD | -279.69% |
| 2016 | -514.36 Thousand NZD | 80.97% |
| 2015 | -2.7 Million NZD | 1.2% |
| 2014 | -2.73 Million NZD | -6925.84% |
| 2013 | 40.08 Thousand NZD | -63.17% |
| 2012 | 108.83 Thousand NZD | 21667.0% |
| 2011 | 500.00 NZD | 0.0% |
| 2010 | - NZD | -100.0% |
| 2009 | 220 Thousand NZD | 526.2% |
| 2008 | -51.61 Thousand NZD | 0.0% |
| 2007 | - NZD | 0.0% |
| 2006 | - NZD | -100.0% |
| 2005 | 50 Thousand NZD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 2.83 Million NZD | 0.0% |
| 2024 Q1 | 3.9 Million NZD | 16.91% |
| 2024 Q2 | 3.9 Million NZD | 0.0% |
| 2024 Q3 | 2.83 Million NZD | -27.49% |
| 2024 FY | 14.31 Million NZD | 39.39% |
| 2023 Q4 | 3.34 Million NZD | 0.0% |
| 2023 FY | 10.26 Million NZD | 107.54% |
| 2023 Q3 | 3.34 Million NZD | 33.63% |
| 2023 Q2 | 2.5 Million NZD | 0.0% |
| 2023 Q1 | 2.5 Million NZD | 39.34% |
| 2022 Q2 | 1.52 Million NZD | 0.0% |
| 2022 Q3 | 1.79 Million NZD | 17.71% |
| 2022 Q4 | 1.79 Million NZD | 0.0% |
| 2022 FY | 4.94 Million NZD | 249.28% |
| 2022 Q1 | 1.52 Million NZD | 23.54% |
| 2021 Q2 | 520.5 Thousand NZD | 0.0% |
| 2021 Q1 | 520.5 Thousand NZD | 780.39% |
| 2021 Q4 | 1.23 Million NZD | 0.0% |
| 2021 FY | -3.31 Million NZD | -308.63% |
| 2021 Q3 | 1.23 Million NZD | 137.08% |
| 2020 Q3 | -76.5 Thousand NZD | -71.91% |
| 2020 FY | -811 Thousand NZD | -4.38% |
| 2020 Q4 | -76.5 Thousand NZD | 0.0% |
| 2020 Q2 | -44.5 Thousand NZD | 0.0% |
| 2020 Q1 | -44.5 Thousand NZD | -105.06% |
| 2019 Q3 | 880 Thousand NZD | 213.77% |
| 2019 FY | -777 Thousand NZD | 86.13% |
| 2019 Q1 | -773.5 Thousand NZD | 17.67% |
| 2019 Q4 | 880 Thousand NZD | 0.0% |
| 2019 Q2 | -773.5 Thousand NZD | 0.0% |
| 2018 Q1 | -1.24 Million NZD | 59.14% |
| 2018 FY | -5.6 Million NZD | -186.89% |
| 2018 Q4 | -939.5 Thousand NZD | 0.0% |
| 2018 Q2 | -1.24 Million NZD | 0.0% |
| 2018 Q3 | -939.5 Thousand NZD | 24.29% |
| 2017 Q3 | -3.03 Million NZD | -1728.69% |
| 2017 Q4 | -3.03 Million NZD | 0.0% |
| 2017 FY | -1.95 Million NZD | -279.69% |
| 2017 Q2 | 186.5 Thousand NZD | 0.0% |
| 2017 Q1 | 186.5 Thousand NZD | -55.75% |
| 2016 FY | -514.36 Thousand NZD | 80.97% |
| 2016 Q4 | 421.44 Thousand NZD | 0.0% |
| 2016 Q1 | 23 Thousand NZD | -93.88% |
| 2016 Q2 | 23 Thousand NZD | 0.0% |
| 2016 Q3 | 421.44 Thousand NZD | 1732.38% |
| 2015 Q4 | 375.98 Thousand NZD | 0.0% |
| 2015 FY | -2.7 Million NZD | 1.2% |
| 2015 Q3 | 375.98 Thousand NZD | 116.31% |
| 2015 Q2 | -2.3 Million NZD | 0.0% |
| 2015 Q1 | -2.3 Million NZD | -62.19% |
| 2014 Q2 | 53.5 Thousand NZD | 0.0% |
| 2014 Q1 | 53.5 Thousand NZD | 102.15% |
| 2014 FY | -2.73 Million NZD | -6925.84% |
| 2014 Q4 | -1.42 Million NZD | 0.0% |
| 2014 Q3 | -1.42 Million NZD | -2756.91% |
| 2013 Q3 | -2.48 Million NZD | 0.0% |
| 2013 Q4 | -2.48 Million NZD | 0.0% |
| 2013 FY | 40.08 Thousand NZD | -63.17% |
| 2012 FY | 108.83 Thousand NZD | 21667.0% |
| 2011 FY | 500.00 NZD | 0.0% |
| 2010 FY | - NZD | -100.0% |
| 2009 FY | 220 Thousand NZD | 526.2% |
| 2008 FY | -51.61 Thousand NZD | 0.0% |
| 2007 FY | - NZD | 0.0% |
| 2006 FY | - NZD | -100.0% |
| 2005 FY | 50 Thousand NZD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Australian Clinical Labs Limited | 247.36 Million AUD | 94.214% |
| BCAL Diagnostics Limited | 3.09 Million AUD | -361.94% |
| Genetic Signatures Limited | -16.2 Million AUD | 188.336% |
| Genetic Technologies Limited | 3.9 Million AUD | -266.537% |
| Healius Limited | 541.2 Million AUD | 97.356% |
| Imagion Biosystems Limited | -3.88 Million AUD | 468.553% |
| Integral Diagnostics Limited | 103.8 Million AUD | 86.213% |
| INOVIQ Ltd | -989.82 Thousand AUD | 1545.851% |
| Microba Life Sciences Limited | -8.58 Million AUD | 266.756% |
| Monash IVF Group Limited | 85.5 Million AUD | 83.262% |
| Rhythm Biosciences Limited | -1.35 Million AUD | 1154.343% |
| Sonic Healthcare Limited | 2.33 Billion AUD | 99.386% |